BRIEF published on 04/08/2024 at 23:17, 2 years 5 months ago Biophytis annonce ses résultats financiers pour 2023 et actualise sur ses activités Biophytis Résultats Financiers 2023 Programmes Cliniques BIO101 Sarcopénie Et COVID-19
BRIEF published on 04/08/2024 at 23:17, 2 years 5 months ago Biophytis Reports 2023 Financial Results and Business Updates Biophytis Financial Results 2023 Sarcopenia BIO101 COVID-19 Treatment
BRIEF published on 04/08/2024 at 23:15, 2 years 5 months ago Biophytis Initiates Phase 2 Clinical Study for Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 GLP-1 Receptor Agonists OBA Phase 2 Study
BRIEF published on 04/08/2024 at 23:15, 2 years 5 months ago Biophytis annonce le lancement de l'étude clinique de phase 2 OBA pour le traitement de l'obésité Biophytis Santé Étude Clinique BIO101 Obésité
BRIEF published on 04/08/2024 at 23:09, 2 years 5 months ago Biophytis annonce ses résultats financiers 2023 et fait le point sur ses activités Biophytis Financement Développement Clinique Résultats Financiers 2023 BIO101
BRIEF published on 04/08/2024 at 23:09, 2 years 5 months ago Biophytis announces its 2023 financial results and provides an update on its activities Biophytis Funding Clinical Development 2023 Financial Results BIO101
BRIEF published on 04/08/2024 at 23:05, 2 years 5 months ago Biophytis Announces Phase 2 Clinical Study in Obesity Treatment with BIO101 Biophytis Obesity Treatment BIO101 OBA Phase 2 Clinical Study GLP-1 Receptor Agonists
BRIEF published on 04/08/2024 at 23:05, 2 years 5 months ago Biophytis annonce une étude clinique de phase 2 sur le traitement de l'obésité avec BIO101 Biophytis BIO101 Étude Clinique De Phase 2 OBA Traitement De L'obésité Agonistes Des Récepteurs GLP-1
BRIEF published on 04/08/2024 at 23:05, 2 years 5 months ago Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
BRIEF published on 04/08/2024 at 23:05, 2 years 5 months ago Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
Published on 10/03/2026 at 02:35, 22 hours 20 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 1 day 11 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 11 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 9 hours 10 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 4 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 5 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 1 day 5 hours ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 17:45, 1 day 7 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 7 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 7 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 7 hours ago Aéroports de Paris SA - Calendrier financier 2027
